Re: Nanoencapsulated anti-CK2 small molecule drug or siRNA specifically targets malignant cancer but not benign cells

Anthony Atala

Research output: Contribution to journalComment/debatepeer-review

Fingerprint Dive into the research topics of 'Re: Nanoencapsulated anti-CK2 small molecule drug or siRNA specifically targets malignant cancer but not benign cells'. Together they form a unique fingerprint.